Altogether, our results indicate a potential anti-inflammatory and anti-fibrotic role for USP25 and make USP25 a promising diagnostic marker and potential therapeutic target in IgG4-RD. The gene discussed is USP25; the disease is immunoglobulin G4-related sclerosing disease.